Vietnam Investment Review on MSN

Brii Bio phase 2b hepatitis B data from ENRICH and ENHANCE studies released

DURHAM, N.C. and BEIJING, July 3, 2026 /PRNewswire/ -- Brii Biosciences Limited ("Brii Bio" or the "Company", stock code: 2137.HK), a biotechnology company developing therapies to improve patient ...

MANE Selects Kinaxis to Strengthen Global Planning Capabilities

Kinaxis® (TSX:KXS), a global leader in end-to-end supply chain planning and orchestration, today announced that MANE, one of ...
Medindia

Brii Bio Announces Topline End-of-Treatment Data from Phase 2b ENRICH and ENHANCE Studies for the Treatment of Chronic Hepatitis B

Global hepatitis report 2024: action for access in low- and middle-income countries. World Health Organization. Retrieved from ...

Lexeo Therapeutics, Inc. (LXEO) Discusses Phase III Program Design and Durable Cardiac Improvements in Friedreich's Ataxia Transcript

Discusses Phase III Program Design and Durable Cardiac Improvements in Friedreich's Ataxia June 29, 2026 2:00 PM ...

Moleculin Reports Positive Phase 2/3 MIRACLE Interim Results, With Annamycin Complete Remission Rates 3-fold Greater than Control

Both Annamycin dose arms outperformed control on the primary endpoint of complete remission (CR): 43% and 36% versus 12% — ...
Green Valley News

Owner of dogs in fatal mauling case pleads guilty

The owner of five dogs who mauled a man to death in March 2025 pleaded guilty to negligent homicide and multiple counts of ...